162 related articles for article (PubMed ID: 37646829)
21. Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients.
Zhang L; Wei WJ; Ji QH; Zhu YX; Wang ZY; Wang Y; Huang CP; Shen Q; Li DS; Wu Y
J Clin Endocrinol Metab; 2012 Apr; 97(4):1250-7. PubMed ID: 22319042
[TBL] [Abstract][Full Text] [Related]
22. Clinical and pathologic predictors of central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective cohort study.
Gui CY; Qiu SL; Peng ZH; Wang M
J Endocrinol Invest; 2018 Apr; 41(4):403-409. PubMed ID: 28884301
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological Findings Associated With Cervical Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Retrospective Study in China.
Shi Y; Yang Z; Heng Y; Ju H; Pan Y; Zhang Y
Cancer Control; 2022; 29():10732748221084926. PubMed ID: 35285273
[TBL] [Abstract][Full Text] [Related]
24. The contributing factors for lateral neck lymph node metastasis in papillary thyroid microcarcinoma (PTMC).
Kim K; Zheng X; Kim JK; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY
Endocrine; 2020 Jul; 69(1):149-156. PubMed ID: 32146654
[TBL] [Abstract][Full Text] [Related]
25. Influence Factors for Lymph Node Metastasis in Papillary Thyroid Carcinoma: Hashimoto's Thyroiditis Has a Weak Effect on Central or Lateral Lymph Node Metastasis.
Zhou L; Chen G; Sheng L; Liu N; Zhang B; Zeng Q; Chen B
Cancer Manag Res; 2021; 13():3953-3961. PubMed ID: 34017198
[TBL] [Abstract][Full Text] [Related]
26. Factors predictive of papillary thyroid micro-carcinoma with bilateral involvement and central lymph node metastasis: a retrospective study.
Zhou YL; Gao EL; Zhang W; Yang H; Guo GL; Zhang XH; Wang OC
World J Surg Oncol; 2012 May; 10():67. PubMed ID: 22540396
[TBL] [Abstract][Full Text] [Related]
27. Bilateral multifocality, a marker for aggressive disease, is not an independent prognostic factor for papillary thyroid microcarcinoma: A propensity score matching analysis.
Yan T; Qiu W; Song J; Ying T; Fan Y; Yang Z
Clin Endocrinol (Oxf); 2021 Jul; 95(1):209-216. PubMed ID: 33660317
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive analysis of the effect of Hashimoto's thyroiditis on the diagnostic efficacy of preoperative ultrasonography on cervical lymph node lesions in papillary thyroid cancer.
Tan HL; Nyarko A; Duan SL; Zhao YX; Chen P; He Q; Zhang ZJ; Chang S; Huang P
Front Endocrinol (Lausanne); 2022; 13():987906. PubMed ID: 36714580
[TBL] [Abstract][Full Text] [Related]
29. Clinical features and therapeutic outcomes of patients with papillary thyroid microcarcinomas and larger tumors.
Zheng W; Wang X; Rui Z; Wang Y; Meng Z; Wang R
Nucl Med Commun; 2019 May; 40(5):477-483. PubMed ID: 30973839
[TBL] [Abstract][Full Text] [Related]
30. The Impact of Coexistent Hashimoto's Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma.
Liu Y; Lv H; Zhang S; Shi B; Sun Y
Front Endocrinol (Lausanne); 2021; 12():772071. PubMed ID: 34867817
[TBL] [Abstract][Full Text] [Related]
31. Management of cN0 papillary thyroid microcarcinoma patients according to risk-scoring model for central lymph node metastasis and predictors of recurrence.
Feng JW; Ye J; Wu WX; Qu Z; Qin AC; Jiang Y
J Endocrinol Invest; 2020 Dec; 43(12):1807-1817. PubMed ID: 32557354
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of risk factors for central lymph node metastasis in papillary thyroid microcarcinoma].
Wang ZH; Zhang YJ; Fu GM; Chen YB
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jan; 54(1):12-17. PubMed ID: 30704163
[No Abstract] [Full Text] [Related]
33. Clinical predictors of lymph node metastasis and survival rate in papillary thyroid microcarcinoma: analysis of 3607 patients at a single institution.
Xu Y; Xu L; Wang J
J Surg Res; 2018 Jan; 221():128-134. PubMed ID: 29229118
[TBL] [Abstract][Full Text] [Related]
34. Lymph node metastasis of papillary thyroid carcinoma in the context of Hashimoto's thyroiditis.
Wang L; Chen J; Yuan X; Wang J; Sun L; Jiang J; Zhang L; Liu M; Zhou Q
BMC Endocr Disord; 2022 Jan; 22(1):12. PubMed ID: 34986823
[TBL] [Abstract][Full Text] [Related]
35. Risk prediction and clinical model building for lymph node metastasis in papillary thyroid microcarcinoma.
Lin DZ; Qu N; Shi RL; Lu ZW; Ji QH; Wu WL
Onco Targets Ther; 2016; 9():5307-16. PubMed ID: 27601922
[TBL] [Abstract][Full Text] [Related]
36. Sonographic and Clinical Features of Papillary Thyroid Microcarcinoma Less than or Equal to Five Millimeters: A Retrospective Study.
Lai X; Zhang B; Jiang Y; Li J; Zhao R; Yang X; Zhang X; Zhu S; Wu Q; Cai S; Zhang Y
PLoS One; 2016; 11(2):e0148567. PubMed ID: 26881783
[TBL] [Abstract][Full Text] [Related]
37. The influence of papillary thyroid microcarcinomas size on the occurrence of lymph node metastases.
Goran M; Markovic I; Buta M; Gavrilovic D; Cvetkovic A; Santrac N; Rakovic M; Milijic NM; Dzodic R
J BUON; 2019; 24(5):2120-2126. PubMed ID: 31786884
[TBL] [Abstract][Full Text] [Related]
38. The Prognosis of Skip Metastasis in Papillary Thyroid Microcarcinoma Is Better Than That of Continuous Metastasis.
Weng HY; Yan T; Qiu WW; Fan YB; Yang ZL
J Clin Endocrinol Metab; 2022 May; 107(6):1589-1598. PubMed ID: 35213704
[TBL] [Abstract][Full Text] [Related]
39. Clinical Analysis of Risk Factors for Cervical Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Retrospective Study of 3686 Patients.
Song J; Yan T; Qiu W; Fan Y; Yang Z
Cancer Manag Res; 2020; 12():2523-2530. PubMed ID: 32308489
[TBL] [Abstract][Full Text] [Related]
40. A nomogram for predicting lateral lymph node metastasis in cN0 unifocal papillary thyroid microcarcinoma.
Huang H; Xu S; Ni S; Wang X; Liu S
BMC Cancer; 2023 Aug; 23(1):718. PubMed ID: 37528388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]